Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 695
Gene Symbol: BTK
BTK
0.010 Biomarker phenotype BEFREE <b>Introduction</b>: Regimens involving intensive immuno-chemotherapy, followed by high-dose therapy and autologous stem cell transplant represent the standard treatment for younger fit patients with mantle cell lymphoma (MCL).Targeted approaches (i.e. ibrutinib, bortezomib, and lenalidomide) represent the backbone of therapy for relapsed cases.<b>Areas covered</b>: Acalabrutinib is a novel small molecule with a butynamide moiety specifically designed to irreversibly inhibit Bruton tyrosine kinase (BTK), which is more potent and selective than ibrutinib. 31738609 2020
Entrez Id: 4194
Gene Symbol: MDM4
MDM4
0.010 AlteredExpression phenotype BEFREE Therefore, we aimed to investigate whether the activation of adenosine receptors improves convulsions outcome in carbamazepine (CBZ) resistant animals and modulates the protein levels of efflux transporters (P-GP, MRP1, MRP2) in brain capillaries. 31634453 2020
Entrez Id: 4437
Gene Symbol: MSH3
MSH3
0.010 AlteredExpression phenotype BEFREE Therefore, we aimed to investigate whether the activation of adenosine receptors improves convulsions outcome in carbamazepine (CBZ) resistant animals and modulates the protein levels of efflux transporters (P-GP, MRP1, MRP2) in brain capillaries. 31634453 2020
Entrez Id: 8482
Gene Symbol: SEMA7A
SEMA7A
0.010 AlteredExpression phenotype BEFREE Conversely, overexpression of Sema7A promoted seizures. 31179640 2020
Entrez Id: 4096
Gene Symbol: MAFD2
MAFD2
0.010 Biomarker phenotype BEFREE MDI-222 enhanced electrically evoked AMPAR-mediated synaptic transmission in the anaesthetised rat at 10 mg/kg (administered intravenously) and did not significantly lower the seizure threshold in the pro-convulsant maximal electroshock threshold test (MEST) at any dose tested up to a maximum of 30 mg/kg (administered by oral gavage (p.o.)). 31766938 2020
Entrez Id: 4087
Gene Symbol: SMAD2
SMAD2
0.010 Biomarker phenotype BEFREE Moreover, inhibiting Smad2/3 phosphorylation with ponatinib or SIS3 also significantly reduced seizure severity, alongside reducing GFAP/CS56 immunoreactivity. 31664678 2020
Entrez Id: 51062
Gene Symbol: ATL1
ATL1
0.010 AlteredExpression phenotype BEFREE The lentivirus-mediated overexpression of atlastin-1 protein in the hippocampus of mice suppressed seizure activity in behavioral experiments. 31729196 2020
Entrez Id: 100130958
Gene Symbol: SYCE1L
SYCE1L
0.010 AlteredExpression phenotype BEFREE Therefore, we aimed to investigate whether the activation of adenosine receptors improves convulsions outcome in carbamazepine (CBZ) resistant animals and modulates the protein levels of efflux transporters (P-GP, MRP1, MRP2) in brain capillaries. 31634453 2020
Entrez Id: 79412
Gene Symbol: KREMEN2
KREMEN2
0.010 Biomarker phenotype BEFREE KRM-II-81 suppressed convulsions in corneal kindled mice. 31694876 2020
Entrez Id: 7439
Gene Symbol: BEST1
BEST1
0.010 Biomarker phenotype BEFREE Here, we report that pharmacological or genetic intervention of the GABA-permeable Bestrophin-1 (Best1) channel prevented the generation of tonic GABA inhibition, disinhibiting CA1 pyramidal neuronal firing and augmenting seizure susceptibility in kainic acid (KA)-induced epileptic mice. 31833596 2020
Entrez Id: 57626
Gene Symbol: KLHL1
KLHL1
0.010 AlteredExpression phenotype BEFREE Therefore, we aimed to investigate whether the activation of adenosine receptors improves convulsions outcome in carbamazepine (CBZ) resistant animals and modulates the protein levels of efflux transporters (P-GP, MRP1, MRP2) in brain capillaries. 31634453 2020
Entrez Id: 3337
Gene Symbol: DNAJB1
DNAJB1
0.010 Biomarker phenotype BEFREE Truncating biallelic variant in DNAJA1, encoding the co-chaperone Hsp40, is associated with intellectual disability and seizures. 30972502 2019
Entrez Id: 1509
Gene Symbol: CTSD
CTSD
0.010 Biomarker phenotype BEFREE Moreover, CatD-deficient mice exhibit hyperactivity and increased sensitivity to seizure, mimicking epileptic behavior in CatD-related LSD patients. 31340140 2019
Entrez Id: 56257
Gene Symbol: MEPCE
MEPCE
0.010 GeneticVariation phenotype BEFREE We report a boy with global developmental delay and seizures carrying the de novo MEPCE nonsense variant c.1552 C > T/p.(Arg518*). mRNA and protein analyses identified nonsense-mediated mRNA decay to underlie the decreased amount of MEPCE in patient fibroblasts followed by LARP7 and 7SK snRNA downregulation and HEXIM1 upregulation. 31467394 2019
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 AlteredExpression phenotype BEFREE By measuring copeptin, the C-terminal part of the AVP prohormone, we recently found strongly increased AVP levels in children with febrile seizures (FS) as compared to children with fever but without seizures. 30605489 2019
Entrez Id: 84890
Gene Symbol: ADO
ADO
0.010 Biomarker phenotype BEFREE All A1AR agonists were efficacious in preventing seizure and promoting survival. 31069755 2019
Entrez Id: 80725
Gene Symbol: SRCIN1
SRCIN1
0.010 Biomarker phenotype BEFREE Furthermore, p140Cap-/- neurons show a premature and enhanced network synchronization and appear more susceptible to 4-aminopyridine-induced seizures in vitro and to kainate-induced seizures in vivo. 29161354 2019
Entrez Id: 23082
Gene Symbol: PPRC1
PPRC1
0.010 Biomarker phenotype BEFREE Compared with the PRC group, the average frequency and duration of seizures were also decreased in the LFS group. 31521425 2019
Entrez Id: 710
Gene Symbol: SERPING1
SERPING1
0.010 AlteredExpression phenotype BEFREE Human hippocampal sclerotic tissues removed after surgery for seizure control, plasma, and serum were used in the following assays: immunostaining for white blood cells in the TLE hippocampus, C-reactive protein in serum, quantification of plasma kallikrein (PKal) and cathepsin B (CatB) activity in serum and plasma, quantification of C1-inhibitor, analysis of high-molecular-weight kininogen (H-kininogen) fragments, and activation of plasma prekallikrein for comparison with healthy controls. 31206169 2019
Entrez Id: 10352
Gene Symbol: WARS2
WARS2
0.010 GeneticVariation phenotype BEFREE Biallelic mutations in WARS2 are rare and have been associated with a spectrum of clinical presentations, including neurodevelopmental disorder with abnormal movements, lactic acidosis with or without seizures (NEMMLAS). 31282308 2019
Entrez Id: 64102
Gene Symbol: TNMD
TNMD
0.010 Biomarker phenotype BEFREE The crystal structure was determined by TEM and X-ray diffraction pattern refinement of whole powder pattern fitting. 31292810 2019
Entrez Id: 3620
Gene Symbol: IDO1
IDO1
0.010 Biomarker phenotype BEFREE Infected C57BL/6J mice up-regulated proinflammatory cytokines, Ido1, and genes encoding the enzymatic cascade responsible for QuinA production in the kynurenine pathway prior to the onset of seizures. 30770561 2019
Entrez Id: 55755
Gene Symbol: CDK5RAP2
CDK5RAP2
0.010 Biomarker phenotype BEFREE Features of autosomal recessive primary microcephaly subtype 3 (MCPH3) also include hyperactivity and seizures. 31102767 2019
Entrez Id: 10987
Gene Symbol: COPS5
COPS5
0.010 AlteredExpression phenotype BEFREE In conclusion, the over-expression of 5-HT6 receptor and activated Jab-1/p-c-Jun plays an important role in pilocarpine-induced seizures and learning-memory impairment. 30694481 2019
Entrez Id: 664617
Gene Symbol: MIR542
MIR542
0.010 AlteredExpression phenotype BEFREE Further functional analysis showed that miR-542-3p overexpression inhibited KA-induced average seizure frequency, damage of hippocampal neuron and cell apoptosis, leading to alleviation of the brain injury in epilepsy rats. miR-542-3p was determined to downregulate TLR4 expression. 31702493 2019